231 related articles for article (PubMed ID: 19002467)
1. Risk of contrast-medium-induced nephropathy in high-risk patients undergoing MDCT--a pooled analysis of two randomized trials.
Thomsen HS; Morcos SK
Eur Radiol; 2009 Apr; 19(4):891-7. PubMed ID: 19002467
[TBL] [Abstract][Full Text] [Related]
2. Contrast-induced nephropathy in patients with chronic kidney disease undergoing computed tomography: a double-blind comparison of iodixanol and iopamidol.
Barrett BJ; Katzberg RW; Thomsen HS; Chen N; Sahani D; Soulez G; Heiken JP; Lepanto L; Ni ZH; Ni ZH; Nelson R
Invest Radiol; 2006 Nov; 41(11):815-21. PubMed ID: 17035872
[TBL] [Abstract][Full Text] [Related]
3. Nephrotoxicity of iso-osmolar iodixanol compared with nonionic low-osmolar contrast media: meta-analysis of randomized controlled trials.
Heinrich MC; Häberle L; Müller V; Bautz W; Uder M
Radiology; 2009 Jan; 250(1):68-86. PubMed ID: 19092091
[TBL] [Abstract][Full Text] [Related]
4. The ACTIVE Trial: comparison of the effects on renal function of iomeprol-400 and iodixanol-320 in patients with chronic kidney disease undergoing abdominal computed tomography.
Thomsen HS; Morcos SK; Erley CM; Grazioli L; Bonomo L; Ni Z; Romano L;
Invest Radiol; 2008 Mar; 43(3):170-8. PubMed ID: 18301313
[TBL] [Abstract][Full Text] [Related]
5. The PREDICT study: a randomized double-blind comparison of contrast-induced nephropathy after low- or isoosmolar contrast agent exposure.
Kuhn MJ; Chen N; Sahani DV; Reimer D; van Beek EJ; Heiken JP; So GJ
AJR Am J Roentgenol; 2008 Jul; 191(1):151-7. PubMed ID: 18562739
[TBL] [Abstract][Full Text] [Related]
6. A meta-analysis of the renal safety of isosmolar iodixanol compared with low-osmolar contrast media.
McCullough PA; Bertrand ME; Brinker JA; Stacul F
J Am Coll Cardiol; 2006 Aug; 48(4):692-9. PubMed ID: 16904536
[TBL] [Abstract][Full Text] [Related]
7. Cardiac Angiography in Renally Impaired Patients (CARE) study: a randomized double-blind trial of contrast-induced nephropathy in patients with chronic kidney disease.
Solomon RJ; Natarajan MK; Doucet S; Sharma SK; Staniloae CS; Katholi RE; Gelormini JL; Labinaz M; Moreyra AE;
Circulation; 2007 Jun; 115(25):3189-96. PubMed ID: 17562951
[TBL] [Abstract][Full Text] [Related]
8. Assessment of renal vasoconstriction in vivo after intra-arterial administration of the isosmotic contrast medium iodixanol compared to the low-osmotic contrast medium iopamidol.
Treitl M; Rupprecht H; Wirth S; Korner M; Reiser M; Rieger J
Nephrol Dial Transplant; 2009 May; 24(5):1478-85. PubMed ID: 19033249
[TBL] [Abstract][Full Text] [Related]
9. Renal toxicity evaluation and comparison between visipaque (iodixanol) and hexabrix (ioxaglate) in patients with renal insufficiency undergoing coronary angiography: the RECOVER study: a randomized controlled trial.
Jo SH; Youn TJ; Koo BK; Park JS; Kang HJ; Cho YS; Chung WY; Joo GW; Chae IH; Choi DJ; Oh BH; Lee MM; Park YB; Kim HS
J Am Coll Cardiol; 2006 Sep; 48(5):924-30. PubMed ID: 16949481
[TBL] [Abstract][Full Text] [Related]
10. High incidence of nephropathy in neurosurgical patients after intra-arterial administration of low-osmolar and iso-osmolar contrast media.
Serafin Z; Karolkiewicz M; Gruszka M; Strózecki P; Lasek W; Odrowaz-Sypniewska G; Manitius J; Beuth W
Acta Radiol; 2011 May; 52(4):422-9. PubMed ID: 21498279
[TBL] [Abstract][Full Text] [Related]
11. Iso-osmolality versus low-osmolality iodinated contrast medium at intravenous contrast-enhanced CT: effect on kidney function.
Nguyen SA; Suranyi P; Ravenel JG; Randall PK; Romano PB; Strom KA; Costello P; Schoepf UJ
Radiology; 2008 Jul; 248(1):97-105. PubMed ID: 18483232
[TBL] [Abstract][Full Text] [Related]
12. [Effectiveness of nephroprotection by the selection of contrast media used during vascular interventions in patients with chronic renal failure?].
Schönefeld E; Höwler S; Osada N; Torsello G
Zentralbl Chir; 2011 Oct; 136(5):426-30. PubMed ID: 22009540
[TBL] [Abstract][Full Text] [Related]
13. Contrast-medium-Induced nephropathy correlated to the ratio between dose in gram iodine and estimated GFR in ml/min.
Nyman U; Almén T; Aspelin P; Hellström M; Kristiansson M; Sterner G
Acta Radiol; 2005 Dec; 46(8):830-42. PubMed ID: 16392608
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the nephrotoxicity of iodixanol in patients with predisposing factors to contrast medium induced nephropathy referred for contrast enhanced computed tomography.
Sandstede JJ; Roth A; Machann W; Kaupert C; Hahn D
Eur J Radiol; 2007 Jul; 63(1):120-3. PubMed ID: 17317065
[TBL] [Abstract][Full Text] [Related]
15. Renal safety in pediatric imaging: randomized, double-blind phase IV clinical trial of iobitridol 300 versus iodixanol 270 in multidetector CT.
Zo'o M; Hoermann M; Balassy C; Brunelle F; Azoulay R; Pariente D; Panuel M; Le Dosseur P
Pediatr Radiol; 2011 Nov; 41(11):1393-400. PubMed ID: 21713440
[TBL] [Abstract][Full Text] [Related]
16. Comparative Effect of Contrast Media Type on the Incidence of Contrast-Induced Nephropathy: A Systematic Review and Meta-analysis.
Eng J; Wilson RF; Subramaniam RM; Zhang A; Suarez-Cuervo C; Turban S; Choi MJ; Sherrod C; Hutfless S; Iyoha EE; Bass EB
Ann Intern Med; 2016 Mar; 164(6):417-24. PubMed ID: 26830055
[TBL] [Abstract][Full Text] [Related]
17. Heart rate variability and heat sensation during CT coronary angiography: Low-osmolar versus iso-osmolar contrast media.
Svensson A; Ripsweden J; Rück A; Aspelin P; Cederlund K; Brismar BT
Acta Radiol; 2010 Sep; 51(7):722-6. PubMed ID: 20568977
[TBL] [Abstract][Full Text] [Related]
18. Effect of iodixanol on renal function immediately after abdominal angiography. Clinical comparison with iomeprol and ioxaglate.
Murakami R; Tajima H; Kumazaki T; Yamamoto K
Acta Radiol; 1998 Jul; 39(4):368-71. PubMed ID: 9685820
[TBL] [Abstract][Full Text] [Related]
19. Contrast media use in patients with chronic kidney disease undergoing coronary angiography: A systematic review and meta-analysis of randomized trials.
Pandya B; Chalhoub JM; Parikh V; Gaddam S; Spagnola J; El-Sayegh S; Bogin M; Kandov R; Lafferty J; Bangalore S
Int J Cardiol; 2017 Feb; 228():137-144. PubMed ID: 27863354
[TBL] [Abstract][Full Text] [Related]
20. Choice of contrast medium in patients with impaired renal function undergoing percutaneous coronary intervention.
Wessely R; Koppara T; Bradaric C; Vorpahl M; Braun S; Schulz S; Mehilli J; Schömig A; Kastrati A;
Circ Cardiovasc Interv; 2009 Oct; 2(5):430-7. PubMed ID: 20031753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
